메뉴 건너뛰기




Volumn 33, Issue 1, 2003, Pages 1-18

Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis

Author keywords

Arthritis; Autoimmune diseases; Inhibitor; Psoriatic; Tumor necrosis factor

Indexed keywords

CYTOKINE; ETANERCEPT; INFLIXIMAB; PLACEBO; TUMOR NECROSIS FACTOR RECEPTOR;

EID: 0041826820     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1053/sarh.2003.50022     Document Type: Article
Times cited : (38)

References (115)
  • 1
    • 0035444539 scopus 로고    scopus 로고
    • Signal transduction by tumor necrosis factor and its relatives
    • Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001;11:372-7.
    • (2001) Trends Cell Biol , vol.11 , pp. 372-377
    • Baud, V.1    Karin, M.2
  • 2
    • 0032922359 scopus 로고    scopus 로고
    • The role of tumor necrosis factor in health and disease
    • Beutler BA. The role of tumor necrosis factor in health and disease J Rheumatol 1999;26(suppl 57):16-21.
    • (1999) J Rheumatol , vol.26 , Issue.SUPPL. 57 , pp. 16-21
    • Beutler, B.A.1
  • 3
    • 0027333425 scopus 로고
    • Tumor necrosis factor, other cytokines and disease
    • Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993;9:317-43.
    • (1993) Annu Rev Cell Biol , vol.9 , pp. 317-343
    • Tracey, K.J.1    Cerami, A.2
  • 4
    • 0032813516 scopus 로고    scopus 로고
    • On the role of tumor-necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease
    • Kollias G, Douni E, Kassiotis G, Kontoyiannis D. On the role of tumor-necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol Rev 1999;169:175-94.
    • (1999) Immunol Rev , vol.169 , pp. 175-194
    • Kollias, G.1    Douni, E.2    Kassiotis, G.3    Kontoyiannis, D.4
  • 5
    • 0035056003 scopus 로고    scopus 로고
    • Anti-TNFα therapy of rheumatoid arthritis: What have we learned?
    • Feldmann M, Maini RN. Anti-TNFα therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001;19:163-96.
    • (2001) Annu Rev Immunol , vol.19 , pp. 163-196
    • Feldmann, M.1    Maini, R.N.2
  • 6
    • 0030055347 scopus 로고    scopus 로고
    • Expression of tumour necrosis factor-alpha (TNF-α) mRNA and protein in pathological thyroid tissue and carcinoma cell lines
    • Aust G, Heuer M, Laue S, Lehmann I, Hofmann A, Heldin N-E, et al. Expression of tumour necrosis factor-alpha (TNF-α) mRNA and protein in pathological thyroid tissue and carcinoma cell lines. Clin Exp Immunol 1996;105:148-54.
    • (1996) Clin Exp Immunol , vol.105 , pp. 148-154
    • Aust, G.1    Heuer, M.2    Laue, S.3    Lehmann, I.4    Hofmann, A.5    Heldin, N.-E.6
  • 7
    • 0028306175 scopus 로고
    • Tumor necrosis factor receptor superfamily members and their ligands
    • Armitage RJ. Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immunol 1994;6:407-13.
    • (1994) Curr Opin Immunol , vol.6 , pp. 407-413
    • Armitage, R.J.1
  • 8
    • 0024501951 scopus 로고
    • Cachectin/tumor necrosis factor-α alters red blood cell kinetics and induces anemia in vivo
    • Moldawer LL, Marano MA, Wei H, Fong Y, Silen ML, Kuo G, et al. Cachectin/tumor necrosis factor-α alters red blood cell kinetics and induces anemia in vivo. FASEB J 1989;3: 1637-43.
    • (1989) FASEB J , vol.3 , pp. 1637-1643
    • Moldawer, L.L.1    Marano, M.A.2    Wei, H.3    Fong, Y.4    Silen, M.L.5    Kuo, G.6
  • 9
    • 0024409917 scopus 로고
    • Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice
    • Johnson RA, Waddelow TA, Caro J, Oliff A, Roodman GD. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood 1989;74: 130-8.
    • (1989) Blood , vol.74 , pp. 130-138
    • Johnson, R.A.1    Waddelow, T.A.2    Caro, J.3    Oliff, A.4    Roodman, G.D.5
  • 10
    • 0027293509 scopus 로고
    • Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes
    • Probert L, Keffer J, Corbella P, Cazlaris H, Patsavoudi E, Stephens S, et al. Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J Immunol 1993;151:1894-906.
    • (1993) J Immunol , vol.151 , pp. 1894-1906
    • Probert, L.1    Keffer, J.2    Corbella, P.3    Cazlaris, H.4    Patsavoudi, E.5    Stephens, S.6
  • 11
    • 0026039673 scopus 로고
    • Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis
    • Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991;10:4025-31.
    • (1991) EMBO J , vol.10 , pp. 4025-4031
    • Keffer, J.1    Probert, L.2    Cazlaris, H.3    Georgopoulos, S.4    Kaslaris, E.5    Kioussis, D.6
  • 12
    • 0029891052 scopus 로고    scopus 로고
    • Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice
    • Georgopoulos S, Plows D, Kollias G. Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflamm 1996;46: 86-97.
    • (1996) J Inflamm , vol.46 , pp. 86-97
    • Georgopoulos, S.1    Plows, D.2    Kollias, G.3
  • 14
    • 0033103805 scopus 로고    scopus 로고
    • Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
    • Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999;10:387-98.
    • (1999) Immunity , vol.10 , pp. 387-398
    • Kontoyiannis, D.1    Pasparakis, M.2    Pizarro, T.T.3    Cominelli, F.4    Kollias, G.5
  • 15
    • 0032214715 scopus 로고    scopus 로고
    • Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens
    • Green EA, Eynon EE, Flavell RA. Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 1998;9:733-43.
    • (1998) Immunity , vol.9 , pp. 733-743
    • Green, E.A.1    Eynon, E.E.2    Flavell, R.A.3
  • 16
    • 0029834839 scopus 로고    scopus 로고
    • Local expression of transgene encoded TNFα in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of autoreactive islet-specific T cells
    • Grewal IS, Grewal KD, Wong FS, Picarella DE, Janeway CA Jr, Flavell RA. Local expression of transgene encoded TNFα in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of autoreactive islet-specific T cells. J Exp Med 1996;184:1963-74.
    • (1996) J Exp Med , vol.184 , pp. 1963-1974
    • Grewal, I.S.1    Grewal, K.D.2    Wong, F.S.3    Picarella, D.E.4    Janeway C.A., Jr.5    Flavell, R.A.6
  • 17
    • 0029900295 scopus 로고    scopus 로고
    • The tumor necrosis factor ligand and receptor families
    • Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-25.
    • (1996) N Engl J Med , vol.334 , pp. 1717-1725
    • Bazzoni, F.1    Beutler, B.2
  • 19
    • 0029989339 scopus 로고    scopus 로고
    • Immune and inflammatory responses in TNFα-deficient mice: A critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response
    • Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNFα-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996;184:1397-411.
    • (1996) J Exp Med , vol.184 , pp. 1397-1411
    • Pasparakis, M.1    Alexopoulou, L.2    Episkopou, V.3    Kollias, G.4
  • 20
    • 0000682810 scopus 로고    scopus 로고
    • Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling
    • Le Hir M, Bluethmann H, Kosco-Vilbois MH, Müller M, Di Padova F, Moore M, et al. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J Exp Med 1996;183:2367-72.
    • (1996) J Exp Med , vol.183 , pp. 2367-2372
    • Le Hir, M.1    Bluethmann, H.2    Kosco-Vilbois, M.H.3    Müller, M.4    Di Padova, F.5    Moore, M.6
  • 21
    • 0029982872 scopus 로고    scopus 로고
    • Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication
    • Vieira LQ, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, Scott P. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunol 1996;157:827-35.
    • (1996) J Immunol , vol.157 , pp. 827-835
    • Vieira, L.Q.1    Goldschmidt, M.2    Nashleanas, M.3    Pfeffer, K.4    Mak, T.5    Scott, P.6
  • 22
    • 0029899586 scopus 로고    scopus 로고
    • Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
    • Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 1996;2:788-94.
    • (1996) Nat Med , vol.2 , pp. 788-794
    • Bruce, A.J.1    Boling, W.2    Kindy, M.S.3    Peschon, J.4    Kraemer, P.J.5    Carpenter, M.K.6
  • 23
    • 0025170855 scopus 로고
    • Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis
    • Tetta C, Camussi G, Modena V, Di Vittorio C, Baglioni C. Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. Ann Rheum Dis 1990;49:665-7.
    • (1990) Ann Rheum Dis , vol.49 , pp. 665-667
    • Tetta, C.1    Camussi, G.2    Modena, V.3    Di Vittorio, C.4    Baglioni, C.5
  • 24
    • 0023712236 scopus 로고
    • Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum
    • Saxne T, Palladino MA Jr. Heinegård D, Talal N, Wollheim FA. Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-5.
    • (1988) Arthritis Rheum , vol.31 , pp. 1041-1045
    • Saxne, T.1    Palladino M.A., Jr.2    Heinegård, D.3    Talal, N.4    Wollheim, F.A.5
  • 25
    • 0024063321 scopus 로고
    • Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis
    • Husby G, Williams RC Jr. Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis. J Autoimmun 1988;1:363-71.
    • (1988) J Autoimmun , vol.1 , pp. 363-371
    • Husby, G.1    Williams R.C., Jr.2
  • 26
    • 0023952058 scopus 로고
    • Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1
    • Hopkins SJ, Humphreys M, Jayson MIV. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol 1988;72:422-7.
    • (1988) Clin Exp Immunol , vol.72 , pp. 422-427
    • Hopkins, S.J.1    Humphreys, M.2    Jayson, M.I.V.3
  • 27
    • 0026091413 scopus 로고
    • Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis
    • Chu CQ, Field M, Feldmann M, Maini RN. Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991:34:1125-32.
    • (1991) Arthritis Rheum , vol.34 , pp. 1125-1132
    • Chu, C.Q.1    Field, M.2    Feldmann, M.3    Maini, R.N.4
  • 28
    • 0025939257 scopus 로고
    • Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: Regulation by tumor necrosis factor-α
    • Haworth C, Brennan FM, Chantry D, Turner M, Maini RN, Feldmann M. Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-α. Eur J Immunol 1991;21:2575-9.
    • (1991) Eur J Immunol , vol.21 , pp. 2575-2579
    • Haworth, C.1    Brennan, F.M.2    Chantry, D.3    Turner, M.4    Maini, R.N.5    Feldmann, M.6
  • 29
    • 0029617952 scopus 로고
    • Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-α antibody with the interleukin-1 receptor antagonist
    • Butler DM, Maini RN, Feldmann M, Brennan FM. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-α antibody with the interleukin-1 receptor antagonist. Eur Cytokine Netw 1995;6:225-30.
    • (1995) Eur Cytokine Netw , vol.6 , pp. 225-230
    • Butler, D.M.1    Maini, R.N.2    Feldmann, M.3    Brennan, F.M.4
  • 30
    • 0022648104 scopus 로고
    • Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors
    • Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986;319:516-8.
    • (1986) Nature , vol.319 , pp. 516-518
    • Bertolini, D.R.1    Nedwin, G.E.2    Bringman, T.S.3    Smith, D.D.4    Mundy, G.R.5
  • 31
    • 0022296893 scopus 로고
    • 2 production by human synovial cells and dermal fibroblasts
    • 2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163-8.
    • (1985) J Exp Med , vol.162 , pp. 2163-2168
    • Dayer, J.M.1    Beutler, B.2    Cerami, A.3
  • 32
    • 0024420347 scopus 로고
    • The role of cytokines in chondrocyte mediated cartilage degradation
    • Shinmei M, Masuda K, Kikuchi T, Shimomura Y. The role of cytokines in chondrocyte mediated cartilage degradation. J Rheumatol 1989;6(suppl 18):32-4.
    • (1989) J Rheumatol , vol.6 , Issue.SUPPL. 18 , pp. 32-34
    • Shinmei, M.1    Masuda, K.2    Kikuchi, T.3    Shimomura, Y.4
  • 33
    • 0032790226 scopus 로고    scopus 로고
    • Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: Localization in the pannus-hard tissue junction and inhibition by alendronate
    • Konttinen YT, Salo T, Hanemaaijer R, Valleala H, Sorsa T, Sutinen M, et al. Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate. Matrix Biol 1999;18: 401-12.
    • (1999) Matrix Biol , vol.18 , pp. 401-412
    • Konttinen, Y.T.1    Salo, T.2    Hanemaaijer, R.3    Valleala, H.4    Sorsa, T.5    Sutinen, M.6
  • 34
    • 0027497004 scopus 로고
    • Transcriptional modulation of cartilage-specific collagen gene expression by interferon γ and tumour necrosis factor α in cultured human chondrocytes
    • Reginato AM, Sanz-Rodriguez C, Diaz A, Dharmavaram RM, Jimenez SA. Transcriptional modulation of cartilage-specific collagen gene expression by interferon γ and tumour necrosis factor α in cultured human chondrocytes. Biochem J 1993;294:761-9.
    • (1993) Biochem J , vol.294 , pp. 761-769
    • Reginato, A.M.1    Sanz-Rodriguez, C.2    Diaz, A.3    Dharmavaram, R.M.4    Jimenez, S.A.5
  • 35
    • 0031936694 scopus 로고    scopus 로고
    • Effects of interferon-γ and tumor necrosis factor α on the expression of the genes encoding aggrecan, biglycan, and decorin core proteins in cultured human chondrocytes
    • Dodge GR, Diaz A, Sanz-Rodriguez C, Reginato AM, Jimenez SA. Effects of interferon-γ and tumor necrosis factor α on the expression of the genes encoding aggrecan, biglycan, and decorin core proteins in cultured human chondrocytes. Arthritis Rheum 1998;41:274-83.
    • (1998) Arthritis Rheum , vol.41 , pp. 274-283
    • Dodge, G.R.1    Diaz, A.2    Sanz-Rodriguez, C.3    Reginato, A.M.4    Jimenez, S.A.5
  • 36
    • 0037758113 scopus 로고    scopus 로고
    • Mechanism of bone destruction in arthritis: Defective control of bone resorption by the immune system
    • Takayanagi H, Oda H, Taniguchi T, Nakamura K. Mechanism of bone destruction in arthritis: defective control of bone resorption by the immune system [abstract]. Arthritis Rheum 2001;44(suppl):S234.
    • (2001) Arthritis Rheum , vol.44 , Issue.SUPPL.
    • Takayanagi, H.1    Oda, H.2    Taniguchi, T.3    Nakamura, K.4
  • 37
    • 0034677177 scopus 로고    scopus 로고
    • Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
    • Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, et al. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 2000;191:275-86.
    • (2000) J Exp Med , vol.191 , pp. 275-286
    • Kobayashi, K.1    Takahashi, N.2    Jimi, E.3    Udagawa, N.4    Takami, M.5    Kotake, S.6
  • 38
    • 0037758111 scopus 로고    scopus 로고
    • Proinflammatory cytokines can directly induce differentiation of human osteoclasts
    • Fujikawa Y, Kudo O, Itonaga I, Taira H, Oita TT. Proinflammatory cytokines can directly induce differentiation of human osteoclasts [abstract]. Arthritis Rheum 2001;44(suppl):S231.
    • (2001) Arthritis Rheum , vol.44 , Issue.SUPPL.
    • Fujikawa, Y.1    Kudo, O.2    Itonaga, I.3    Taira, H.4    Oita, T.T.5
  • 39
    • 0034009870 scopus 로고    scopus 로고
    • Pathogenesis of bone erosions in rheumatoid arthritis
    • Goldring SR, Gravallese EM. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 2000;12: 195-9.
    • (2000) Curr Opin Rheumatol , vol.12 , pp. 195-199
    • Goldring, S.R.1    Gravallese, E.M.2
  • 40
    • 0030905089 scopus 로고    scopus 로고
    • Highly increased levels of tumor necrosis factor-α and other proinflammatory cytokines in psoriatic arthritis synovial fluid
    • Partsch G, Steiner G, Leeb BF, Dunky A, Bröll H, Smolen JS. Highly increased levels of tumor necrosis factor-α and other proinflammatory cytokines in psoriatic arthritis synovial fluid. J Rheumatol 1997;24:518-23.
    • (1997) J Rheumatol , vol.24 , pp. 518-523
    • Partsch, G.1    Steiner, G.2    Leeb, B.F.3    Dunky, A.4    Bröll, H.5    Smolen, J.S.6
  • 42
    • 0028903218 scopus 로고
    • Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis
    • Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995;38:499-505.
    • (1995) Arthritis Rheum , vol.38 , pp. 499-505
    • Braun, J.1    Bollow, M.2    Neure, L.3    Seipelt, E.4    Seyrekbasan, F.5    Herbst, H.6
  • 43
    • 0027532596 scopus 로고
    • In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis
    • Noronha IL, Krüger C, Andrassy K, Ritz E, Waldherr R. In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 1993;43:682-92.
    • (1993) Kidney Int , vol.43 , pp. 682-692
    • Noronha, I.L.1    Krüger, C.2    Andrassy, K.3    Ritz, E.4    Waldherr, R.5
  • 44
  • 46
    • 0004240964 scopus 로고    scopus 로고
    • Seattle, Wash: Immunex Corporation
    • Enbrel [package insert]. Seattle, Wash: Immunex Corporation, 2002.
    • (2002) Enbrel [Package Insert]
  • 47
    • 0027198002 scopus 로고
    • Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
    • Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993;151:1548-61.
    • (1993) J Immunol , vol.151 , pp. 1548-1561
    • Mohler, K.M.1    Torrance, D.S.2    Smith, C.A.3    Goodwin, R.G.4    Stremler, K.E.5    Fung, V.P.6
  • 48
    • 0035012652 scopus 로고    scopus 로고
    • Anti-tumor necrosis factor therapies
    • Taylor PC. Anti-tumor necrosis factor therapies. Curr Opin Rheumatol 2001;13:164-9.
    • (2001) Curr Opin Rheumatol , vol.13 , pp. 164-169
    • Taylor, P.C.1
  • 49
    • 0027361432 scopus 로고
    • Construction and initial characterization of a mouse-human chimeric anti-TNF antibody
    • Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M, et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol 1993;30:1443-53.
    • (1993) Mol Immunol , vol.30 , pp. 1443-1453
    • Knight, D.M.1    Trinh, H.2    Le, J.3    Siegel, S.4    Shealy, D.5    McDonough, M.6
  • 50
    • 0013255902 scopus 로고    scopus 로고
    • High sensitivity cytometric analysis of membrane- and receptor-bound TNFα on T cells - Effects of anti-TNF treatment in vitro
    • Kohler S, Thiel A, Radbruch A, Sieper J, Braun J. High sensitivity cytometric analysis of membrane- and receptor-bound TNFα on T cells - effects of anti-TNF treatment in vitro [abstract]. Arthritis Rheum 2000;43:S101.
    • (2000) Arthritis Rheum , vol.43
    • Kohler, S.1    Thiel, A.2    Radbruch, A.3    Sieper, J.4    Braun, J.5
  • 51
    • 0003547850 scopus 로고    scopus 로고
    • Malvern, Pa: Centocor, Inc.
    • Remicade [package insert]. Malvern, Pa: Centocor, Inc, 2002.
    • (2002) Remicade [Package Insert]
  • 52
    • 0029671297 scopus 로고    scopus 로고
    • In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-α antibody in patients with rheumatoid arthritis. Short-term cellular and molecular effects
    • Lorenz H-M, Antoni C, Valerius T, Repp R, Grünke M, Schwerdtner N, et al. In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-α antibody in patients with rheumatoid arthritis. Short-term cellular and molecular effects. J Immunol 1996;156:1646-53.
    • (1996) J Immunol , vol.156 , pp. 1646-1653
    • Lorenz, H.-M.1    Antoni, C.2    Valerius, T.3    Repp, R.4    Grünke, M.5    Schwerdtner, N.6
  • 53
    • 0031660364 scopus 로고    scopus 로고
    • Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
    • Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-63.
    • (1998) Arthritis Rheum , vol.41 , pp. 1552-1563
    • Maini, R.N.1    Breedveld, F.C.2    Kalden, J.R.3    Smolen, J.S.4    Davis, D.5    Macfarlane, J.D.6
  • 54
    • 85031084964 scopus 로고    scopus 로고
    • National Psoriasis Foundation Web site. About psoriasis: psoriatic arthritis. Available at: http://www.psoriasis.org/ b300.htm. Accessed November 1, 2001.
    • About Psoriasis: Psoriatic Arthritis
  • 59
    • 0034729950 scopus 로고    scopus 로고
    • Etanercept in the treatment of psoriatic arthritis and psoriasis: A randomised trial
    • Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 2000;356:385-90.
    • (2000) Lancet , vol.356 , pp. 385-390
    • Mease, P.J.1    Goffe, B.S.2    Metz, J.3    VanderStoep, A.4    Finck, B.5    Burge, D.J.6
  • 60
    • 0001997773 scopus 로고    scopus 로고
    • Improvement in disease activity in patients with psoriatic arthritis receiving etanercept (Enbrel): Results of a phase 3 multicenter clinical trial
    • Mease P, Kivitz A, Burch F, Siegel E, Cohen S, Burge D. Improvement in disease activity in patients with psoriatic arthritis receiving etanercept (Enbrel): results of a phase 3 multicenter clinical trial [abstract]. Arthritis Rheum 2001;44 (suppl):S90.
    • (2001) Arthritis Rheum , vol.44 , Issue.SUPPL.
    • Mease, P.1    Kivitz, A.2    Burch, F.3    Siegel, E.4    Cohen, S.5    Burge, D.6
  • 62
    • 0033770713 scopus 로고    scopus 로고
    • From wheels to feet: A dramatic response of severe chronic psoriatic arthritis to etanercept
    • Elkayam O, Yaron M, Caspi D. From wheels to feet: a dramatic response of severe chronic psoriatic arthritis to etanercept [letter]. Ann Rheum Dis 2000;59:839-40.
    • (2000) Ann Rheum Dis , vol.59 , pp. 839-840
    • Elkayam, O.1    Yaron, M.2    Caspi, D.3
  • 64
    • 0034130272 scopus 로고    scopus 로고
    • Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: An open pilot study
    • Van den Bosch F, Kruithof E, Baeten D, De Keyser F, Mielants H, Veys EM. Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study. Ann Rheum Dis 2000;59:428-33.
    • (2000) Ann Rheum Dis , vol.59 , pp. 428-433
    • Van den Bosch, F.1    Kruithof, E.2    Baeten, D.3    De Keyser, F.4    Mielants, H.5    Veys, E.M.6
  • 67
    • 0035083651 scopus 로고    scopus 로고
    • Treatment of psoriatic arthritis with antitumour necrosis factor-α antibody clears skin lesions of psoriasis resistant to treatment with methotrexate
    • Ogilvie AL, Antoni C, Dechant C, Manger B, Kalden JR, Schuler G, et al. Treatment of psoriatic arthritis with antitumour necrosis factor-α antibody clears skin lesions of psoriasis resistant to treatment with methotrexate. Br J Dermatol 2001;144: 587-9.
    • (2001) Br J Dermatol , vol.144 , pp. 587-589
    • Ogilvie, A.L.1    Antoni, C.2    Dechant, C.3    Manger, B.4    Kalden, J.R.5    Schuler, G.6
  • 70
    • 0000528734 scopus 로고    scopus 로고
    • Emerging role of infliximab (Remicade) in psoriatic arthritis patients resistant to disease-modifying antirheumatic drugs: Case studies
    • Bray VJ, Huffstutter JE, Schwartzman S. Emerging role of infliximab (Remicade) in psoriatic arthritis patients resistant to disease-modifying antirheumatic drugs: case studies [abstract]. Arthritis Rheum 2001;44(suppl):S121.
    • (2001) Arthritis Rheum , vol.44 , Issue.SUPPL.
    • Bray, V.J.1    Huffstutter, J.E.2    Schwartzman, S.3
  • 71
    • 0035832515 scopus 로고    scopus 로고
    • Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomised trial
    • Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 2001;357:1842-7.
    • (2001) Lancet , vol.357 , pp. 1842-1847
    • Chaudhari, U.1    Romano, P.2    Mulcahy, L.D.3    Dooley, L.T.4    Baker, D.G.5    Gottlieb, A.B.6
  • 72
    • 0000998464 scopus 로고    scopus 로고
    • Etanercept in the treatment of ankylosing spondylitis: A randomized, double-blind, placebo-controlled study
    • Gorman JD, Sack KE, Davis JC Jr. Etanercept in the treatment of ankylosing spondylitis: a randomized, double-blind, placebo-controlled study [abstract]. Arthritis Rheum 2000;43(suppl):S403.
    • (2000) Arthritis Rheum , vol.43 , Issue.SUPPL.
    • Gorman, J.D.1    Sack, K.E.2    Davis J.C., Jr.3
  • 73
    • 0037007683 scopus 로고    scopus 로고
    • Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha
    • Gorman JD, Sack KE, Davis JCJ. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002;346:1349-56.
    • (2002) N Engl J Med , vol.346 , pp. 1349-1356
    • Gorman, J.D.1    Sack, K.E.2    Davis, J.C.J.3
  • 75
    • 4243646897 scopus 로고    scopus 로고
    • An open-label trial of etanercept in the treatment of ankylosing spondylitis
    • Abstract 230
    • Gorman JD, Sack KE, Davis JC. An open-label trial of etanercept in the treatment of ankylosing spondylitis [abstract]. Arthritis Rheum 2001;44(suppl):S91. Abstract 230.
    • (2001) Arthritis Rheum , vol.44 , Issue.SUPPL.
    • Gorman, J.D.1    Sack, K.E.2    Davis, J.C.3
  • 76
    • 85059110785 scopus 로고    scopus 로고
    • Rapid and complete remission in treatment resistant ankylosing spondylitis with etanercept - A better drug for refractory AS than for refractory RA?
    • Barthel HR. Rapid and complete remission in treatment resistant ankylosing spondylitis with etanercept - a better drug for refractory AS than for refractory RA? [abstract]. Ann Rheum Dis 2001;60:AB0125
    • (2001) Ann Rheum Dis , vol.60
    • Barthel, H.R.1
  • 77
    • 0035459313 scopus 로고    scopus 로고
    • Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: A clinical and magnetic resonance imaging study
    • Marzo-Ortega H, McGonagle D, O'Connor P, Emery P. Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study. Arthritis Rheum 2001;44:2112-7.
    • (2001) Arthritis Rheum , vol.44 , pp. 2112-2117
    • Marzo-Ortega, H.1    McGonagle, D.2    O'Connor, P.3    Emery, P.4
  • 78
    • 0000100892 scopus 로고    scopus 로고
    • Prolonged efficacy of etanercept in refractory juvenile ankylosing spondylitis
    • Abstract 1434
    • Reiff A, Henrickson M. Prolonged efficacy of etanercept in refractory juvenile ankylosing spondylitis [abstract]. Arthritis Rheum 2001;44(suppl):S292. Abstract 1434.
    • (2001) Arthritis Rheum , vol.44 , Issue.SUPPL.
    • Reiff, A.1    Henrickson, M.2
  • 79
    • 0001609742 scopus 로고    scopus 로고
    • Efficacy of etanercept in refractory juvenile spondyloarthropathy
    • Henrickson M. Efficacy of etanercept in refractory juvenile spondyloarthropathy [abstract]. Arthritis Rheum 2000;43: S257.
    • (2000) Arthritis Rheum , vol.43
    • Henrickson, M.1
  • 80
    • 0002044825 scopus 로고    scopus 로고
    • Quality of life improvement in patients with severe ankylosing spondylitis upon treatment with the anti-TNFα antibody infliximab in a placebo controlled multicenter trial
    • Abstract 221
    • Brandt J, Listing J, Alten R, Krause A, Gromnica-Ihle E, Kellner H, et al. Quality of life improvement in patients with severe ankylosing spondylitis upon treatment with the anti-TNFα antibody infliximab in a placebo controlled multicenter trial [abstract]. Arthritis Rheum 2001;44(suppl):S89. Abstract 221.
    • (2001) Arthritis Rheum , vol.44 , Issue.SUPPL.
    • Brandt, J.1    Listing, J.2    Alten, R.3    Krause, A.4    Gromnica-Ihle, E.5    Kellner, H.6
  • 81
    • 85031084219 scopus 로고    scopus 로고
    • Successful treatment of patients with severe undifferentiated spondyloarthropathy with the anti-TNFa antibody infliximab
    • June 13-16; Prague, Czech Republic. Abstract SAT0022
    • Brandt J, Haibel H, Sieper J, Braun J. Successful treatment of patients with severe undifferentiated spondyloarthropathy with the anti-TNFa antibody infliximab [abstract]. Presented at: European League Against Rheumatism (EULAR)/European Congress of Rheumatology; June 13-16, 2001; Prague, Czech Republic. Abstract SAT0022.
    • (2001) European League Against Rheumatism (EULAR)/European Congress of Rheumatology
    • Brandt, J.1    Haibel, H.2    Sieper, J.3    Braun, J.4
  • 82
    • 4243824012 scopus 로고    scopus 로고
    • Efficacy of infliximab in severe refractory ankylosing spondylitis (AS): Results of a 6 months follow-up open-label study
    • Breban M. Vignon E, Claudepierre P, Saraux A, Wendling D, Lespessailles E, et al. Efficacy of infliximab in severe refractory ankylosing spondylitis (AS): results of a 6 months follow-up open-label study [abstract]. Arthritis Rheum 2001; 44:S89.
    • (2001) Arthritis Rheum , vol.44
    • Breban, M.1    Vignon, E.2    Claudepierre, P.3    Saraux, A.4    Wendling, D.5    Lespessailles, E.6
  • 84
    • 0002219072 scopus 로고    scopus 로고
    • Infliximab in the treatment of spondylarthropathy, bone mineral density effect
    • Abstract 220
    • Allali F, Roux C, Kolta S, Claudepierre P, Lespessailles E, Dougados M, et al. Infliximab in the treatment of spondylarthropathy, bone mineral density effect [abstract]. Arthritis Rheum 2001;44(suppl):S89. Abstract 220.
    • (2001) Arthritis Rheum , vol.44 , Issue.SUPPL.
    • Allali, F.1    Roux, C.2    Kolta, S.3    Claudepierre, P.4    Lespessailles, E.5    Dougados, M.6
  • 86
    • 0027740303 scopus 로고
    • Overproduction of monocyte derived tumor necrosis factor α, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects
    • Mege J-L, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, et al. Overproduction of monocyte derived tumor necrosis factor α, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993;20:1544-9.
    • (1993) J Rheumatol , vol.20 , pp. 1544-1549
    • Mege, J.-L.1    Dilsen, N.2    Sanguedolce, V.3    Gul, A.4    Bongrand, P.5    Roux, H.6
  • 87
    • 0031029814 scopus 로고    scopus 로고
    • Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet's disease; soluble TNFR-75 as a biological marker of disease activity
    • Turan B, Gallati H, Erdi H, Gürler A, Michel BA, Villiger PM. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 1997;24: 128-32.
    • (1997) J Rheumatol , vol.24 , pp. 128-132
    • Turan, B.1    Gallati, H.2    Erdi, H.3    Gürler, A.4    Michel, B.A.5    Villiger, P.M.6
  • 89
  • 90
    • 0034775499 scopus 로고    scopus 로고
    • Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor α antibody
    • Travis SPL, Czajkowski M, McGovern DPB, Watson RGP, Bell AL. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor α antibody. Gut 2001;49: 725-8.
    • (2001) Gut , vol.49 , pp. 725-728
    • Travis, S.P.L.1    Czajkowski, M.2    McGovern, D.P.B.3    Watson, R.G.P.4    Bell, A.L.5
  • 91
    • 4243282205 scopus 로고    scopus 로고
    • Behcet disease associated with severe gastroparesis: A dramatic response to combination therapy with methotrexate and infliximab
    • Abstract 408
    • Bertken R. Behcet disease associated with severe gastroparesis: a dramatic response to combination therapy with methotrexate and infliximab [abstract]. Arthritis Rheum 2001; 44(suppl):S120. Abstract 408.
    • (2001) Arthritis Rheum , vol.44 , Issue.SUPPL.
    • Bertken, R.1
  • 92
    • 0035033807 scopus 로고    scopus 로고
    • Etanercept combined with conventional treatment in Wegener's granulomatosis: A six-month open-label trial to evaluate safety
    • Stone JH, Uhlfelder ML, Hellmann DB, Crook S, Bedocs NM, Hoffman GS. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety. Arthritis Rheum 2001;44: 1149-54.
    • (2001) Arthritis Rheum , vol.44 , pp. 1149-1154
    • Stone, J.H.1    Uhlfelder, M.L.2    Hellmann, D.B.3    Crook, S.4    Bedocs, N.M.5    Hoffman, G.S.6
  • 94
    • 0025354569 scopus 로고
    • Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis
    • Deguchi Y, Shibata N, Kishimoto S. Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis. Clin Exp Immunol 1990;81:311-4.
    • (1990) Clin Exp Immunol , vol.81 , pp. 311-314
    • Deguchi, Y.1    Shibata, N.2    Kishimoto, S.3
  • 95
    • 0000372157 scopus 로고    scopus 로고
    • Phase I/II trial of etanercept in Wegener's granulomatosis (WG): Safety and preliminary experience
    • Langford CA, Talar-Williams C, Barron KS, McCabe KE, Sneller MC. Phase I/II trial of etanercept in Wegener's granulomatosis (WG): safety and preliminary experience [abstract]. Arthritis Rheum 2000;43(suppl):S163.
    • (2000) Arthritis Rheum , vol.43 , Issue.SUPPL.
    • Langford, C.A.1    Talar-Williams, C.2    Barron, K.S.3    McCabe, K.E.4    Sneller, M.C.5
  • 96
    • 0001846855 scopus 로고    scopus 로고
    • Successful treatment of refractory Wegener's granulomatosis with infliximab
    • Abstract 24
    • Lamprecht P, Voswinkel J, Lilienthal T, Noelle B, Heller M, Gross WL, et al. Successful treatment of refractory Wegener's granulomatosis with infliximab [abstract]. Arthritis Rheum 2001;44(suppl):S56. Abstract 24.
    • (2001) Arthritis Rheum , vol.44 , Issue.SUPPL.
    • Lamprecht, P.1    Voswinkel, J.2    Lilienthal, T.3    Noelle, B.4    Heller, M.5    Gross, W.L.6
  • 97
    • 0033623341 scopus 로고    scopus 로고
    • TNFα-308A allele in juvenile dermatomyositis: Association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications
    • Pachman LM, Liotta-Davis MR, Hong DK, Kinsella TR, Mendez EP, Kinder JM, et al. TNFα-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications. Arthritis Rheum 2000;43:2368-77.
    • (2000) Arthritis Rheum , vol.43 , pp. 2368-2377
    • Pachman, L.M.1    Liotta-Davis, M.R.2    Hong, D.K.3    Kinsella, T.R.4    Mendez, E.P.5    Kinder, J.M.6
  • 98
    • 0033023483 scopus 로고    scopus 로고
    • Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies
    • De Bleecker JL, Meire VI, Declercq W, Van Aken EH. Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies. Neuromuscul Disord 1999;9:239-46.
    • (1999) Neuromuscul Disord , vol.9 , pp. 239-246
    • De Bleecker, J.L.1    Meire, V.I.2    Declercq, W.3    Van Aken, E.H.4
  • 100
    • 0030904859 scopus 로고    scopus 로고
    • Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies
    • Lundberg I, Ulfgren A-K, Nyberg P, Andersson U, Klareskog L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997;40:865-74.
    • (1997) Arthritis Rheum , vol.40 , pp. 865-874
    • Lundberg, I.1    Ulfgren, A.-K.2    Nyberg, P.3    Andersson, U.4    Klareskog, L.5
  • 101
    • 0003129462 scopus 로고    scopus 로고
    • Successful use of infliximab in a case of refractory juvenile dermatomyositis
    • Abstract 228
    • Nzeusseu A, Durez P, Houssiau FA, Devogelaer J-P. Successful use of infliximab in a case of refractory juvenile dermatomyositis [abstract]. Arthritis Rheum 2001;44(suppl): S90. Abstract 228.
    • (2001) Arthritis Rheum , vol.44 , Issue.SUPPL.
    • Nzeusseu, A.1    Durez, P.2    Houssiau, F.A.3    Devogelaer, J.-P.4
  • 102
    • 0000716938 scopus 로고    scopus 로고
    • Experience with etanercept in chronic juvenile dermatomyositis (JDM): Preliminary results
    • Miller ML, Mendez E, Klein-Gitelman MS, Pachman LM. Experience with etanercept in chronic juvenile dermatomyositis (JDM): preliminary results [abstract]. Arthritis Rheum 2000;43(suppl):S380.
    • (2000) Arthritis Rheum , vol.43 , Issue.SUPPL.
    • Miller, M.L.1    Mendez, E.2    Klein-Gitelman, M.S.3    Pachman, L.M.4
  • 103
    • 0001513397 scopus 로고    scopus 로고
    • Etanercept is effective in the treatment of polymyositis/dermatomyositis which is refractory to conventional therapy including steroids and other disease modifying agents
    • Saadeh CK. Etanercept is effective in the treatment of polymyositis/dermatomyositis which is refractory to conventional therapy including steroids and other disease modifying agents [abstract]. Arthritis Rheum 2000;43(suppl):S193.
    • (2000) Arthritis Rheum , vol.43 , Issue.SUPPL.
    • Saadeh, C.K.1
  • 106
    • 0027417964 scopus 로고
    • Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis
    • Steffen M, Petersen J, Oldigs M, Karmeier A, Magnussen H, Thiele HG, et al. Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis. J Allergy Clin Immunol 1993;91:939-49.
    • (1993) J Allergy Clin Immunol , vol.91 , pp. 939-949
    • Steffen, M.1    Petersen, J.2    Oldigs, M.3    Karmeier, A.4    Magnussen, H.5    Thiele, H.G.6
  • 107
    • 0029744588 scopus 로고    scopus 로고
    • Increased expression of tumor necrosis factor-α, interleukin-6, platelet-derived growth factor-β and granulocyte-macrophage-colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis
    • Ishioka S, Saito T, Hiyama K, Haruta Y, Maeda A, Hozawa S, et al. Increased expression of tumor necrosis factor-α, interleukin-6, platelet-derived growth factor-β and granulocyte-macrophage-colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1996;13:139-45.
    • (1996) Sarcoidosis Vasc Diffuse Lung Dis , vol.13 , pp. 139-145
    • Ishioka, S.1    Saito, T.2    Hiyama, K.3    Haruta, Y.4    Maeda, A.5    Hozawa, S.6
  • 108
    • 0035800027 scopus 로고    scopus 로고
    • Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-α therapy
    • Yee AMF, Pochapin MB. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-α therapy. Ann Intern Med 2001;135:27-31.
    • (2001) Ann Intern Med , vol.135 , pp. 27-31
    • Yee, A.M.F.1    Pochapin, M.B.2
  • 111
  • 112
    • 0042776053 scopus 로고    scopus 로고
    • Treatment of rheumatoid vasculitis with infliximab
    • 60:FRI0047
    • Kayser M, Unger L, Nüßlein H. Treatment of rheumatoid vasculitis with infliximab [abstract]. Ann Rheum Dis 2001; 60:FRI0047.
    • (2001) Ann Rheum Dis
    • Kayser, M.1    Unger, L.2    Nüßlein, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.